IMMClock reveals immune aging and T cell function at single-cell resolution

Yael Gurevich Schmidt,Di Wu,Sanna Madan,Sanju Sinha,Sahil Sahni,Vishaka Gopalan,Binbin Wang,Saugato Rahman Dhruba,Alejandro A Schaffer,Nan-ping Weng,Nicholas P Restifo,Kun Wang,Eytan Ruppin

DOI: https://doi.org/10.1101/2024.11.13.623449

2024-11-15

Abstract:The aging of the immune system substantially impacts individual immune responses, yet accurately quantifying immune age remains a complex challenge. Here we developed IMMClock, a novel immune aging clock that uses gene expression data to predict the biological age of individual CD8⁺ T cells, CD4⁺ T cells, and NK cells. The accuracy of IMMClock is first validated across multiple independent datasets, demonstrating its robustness. Second, utilizing the IMMClock, we find that intrinsic cellular aging processes are more strongly altered during immune aging than differentiation processes. Thirdly, our analysis confirms the strong associations between immune aging and established processes such as cellular senescence, exhaustion, and telomere length at the single cell level. Furthermore, immune aging is accelerated under several disease conditions such as type 2 diabetes, heart disease, and cancer. Finally, we apply IMMClock to analyze a perturb-seq gene activation screen of T cell functionality. We find that the post-perturbation immune age of individual T cells is strongly correlated with their pre-perturbation immune age. Furthermore, the immune age at resting state of individual T cells is strongly predictive of their post-stimulation activation state. Overall, IMMClock advances our understanding of immune aging by providing precise, single-cell level age estimations. Its future applications hold promise for identifying interventions that concomitantly rejuvenate and activate T cells, potentially enhancing efforts to counteract age-related immune decline.

Bioinformatics

What problem does this paper attempt to address?

The problem that this paper attempts to solve is:

The aging of the immune system has a significant impact on an individual's immune response, but accurately quantifying immune age remains a complex challenge. To this end, the research team has developed **IMMClock**, a new immune - aging clock that uses gene expression data to predict the biological age of single CD8⁺ T cells, CD4⁺ T cells and natural killer (NK) cells. Through this method, researchers hope to gain a deeper understanding of how the immune system changes with age, especially how the function of T cells is affected by aging.

Specifically, the main objectives of the paper include:
1. **Develop and validate IMMClock**: First, validate the accuracy of IMMClock in multiple independent datasets to demonstrate its robustness.
2. **Explore the relationship between the intrinsic cell - aging process and the differentiation process**: Use IMMClock to discover that the intrinsic cell - aging process is more strongly affected in immune aging than the differentiation process.
3. **Confirm the association between immune aging and known processes**: Analysis confirms that there is a strong association between immune aging and cell aging, exhaustion and telomere length, and these associations are evident at the single - cell level.
4. **Study the acceleration of immune aging under disease conditions**: Discover that immune aging is accelerated under disease conditions such as type 2 diabetes, heart disease and cancer.
5. **Analyze the gene activation screening of T - cell function**: Apply IMMClock to analyze the gene activation screening of T - cell function, and find that the immune age after interference is closely related to the immune age before interference, and the immune age of T cells in the resting state can strongly predict their activation state after stimulation.

Overall, IMMClock advances the understanding of immune aging by providing accurate single - cell - level age estimates and may be used in the future to identify interventions that simultaneously restore and activate T cells, thereby combating age - related immune decline.